医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Fabrinet Announces Audit Committee Investigation into Accounting Matters; Postpones Fourth Quarter and Fiscal Year 2014 Earnings Release and Conference Call

2014年08月18日 PM09:30
このエントリーをはてなブックマークに追加


 

BANGKOK

Fabrinet (NYSE:FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, today announced that during the fourth quarter of the fiscal year ended June 27, 2014, certain accounting issues were discovered by management, which prompted the Audit Committee to commence an internal investigation. The Audit Committee is investigating whether there were any violations of the Company’s accounting policies associated with these potential accounting matters. The Company has also notified the SEC of the Audit Committee’s investigation.

The Audit Committee has not reached any conclusion because the investigation is ongoing, and the Company cannot predict the outcome of the investigation or when it will be completed. The Company is also currently evaluating whether there may be any deficiencies with the Company’s disclosure controls and procedures and internal control over financial reporting.

As a result, the Company is postponing its fourth quarter and fiscal year 2014 earnings release and conference call, which had been scheduled for August 18, 2014. Fabrinet will announce such results as soon as practicable following the completion of the Audit Committee’s investigation.

About Fabrinet

Fabrinet is a leading provider of advanced optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and subsystems, industrial lasers and sensors. Fabrinet offers a broad range of advanced optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, advanced packaging, integration, final assembly and test. Fabrinet focuses on production of high complexity products in any mix and any volume. Fabrinet maintains engineering and manufacturing resources and facilities in Thailand, the People’s Republic of China and the United States. For more information visit: www.fabrinet.com.

CONTACT

Investors:
Jennifer Predmore, 215-428-1797
ir@fabrinet.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 印尼生命科学与技术学院在NCRM NICHE 2021上赢得第16届Fujio Cup Quiz大赛;印度Rajalakshmi工程学院获得亚军
  • 辉凌将在ACG 2021上展示基于微生物群的在研活体生物治疗药物RBX2660用于治疗艰难梭菌反复感染和IBD患者的获奖真实临床转归分析
  • ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
  • 硕迪B轮成功融资1亿美元,利用先进的计算和结构药物设计平台加速开发改变患者命运的药物
  • CANbridge Pharmaceuticals CAN103 Investigational New Drug Application Approved in China for Treatment of Gaucher Disease